Why Amgen’s $28 Billion Merger News Also Bodes Well For Pfizer, Biogen
Investor's Business DailyAmgen stock rose Friday after the FTC dropped its lawsuit, clearing the way for the biotech to buy Horizon Therapeutics for $28 billion.
The post Why Amgen's $28 Billion Merger News Also Bodes Well For Pfizer, Biogen appeared first on Investor…